Biotrin International - Company Logo
 
 
parvovirus b19 fifth disease
  Welcome to Biotrin
  Biotrin is a healthcare company that specialises in providing a range of novel and proprietary tests for the clinician and research scientist. Biotrin’s headquarters are in Dublin, Ireland where it conducts its research and development, manufacturing and marketing activities.
  News
 18 Jun 2010Biotrin Group Announce Research and Development project for Dublin with the Creation of 40 new jobs
 25 Mar 2010BioMedica Conference, Dublin, Ireland 27th-28th April 2010
 25 Mar 2010Clinical Virology Symposium, Daytona Beach, Florida USA, April 25-28th 2010
biomarkers
Infectious Diseases

Biotrin’s lead product range are tests to detect Parvovirus B19, a viral infection that can cause miscarriage in pregnant women. Biotrin is the world leader in Parvovirus B19 testing and the only company to have FDA cleared tests. Other CE marked tests: HHV-6, HHV-8, Hantavirus and Respiratory viruses

JUST LAUNCHED Human metapneumovirus (hMPV)
A newly identified respiratory virus that has been shown to be the causative agent to acute respiratory tract infections (ARTI) world-wide (from mild upper respiratory infection’s, bronchiolitis and pneumonia).


Biotrin’s unique range of histologically defined biomarker panels for Early Organ Damage Detection in:


Kidney
 Liver
 Pancreas
 OxyDNA


Biotrin’s “Acute Kidney Injury Test”. Now available!!

Biotrin biomarker panels provide the clinician / researcher with precise information regarding the site and extent of injury in the kidney, liver and pancreas of both rat and man.
“Be Early, Be Sure, Be Safe”

© 2005 Biotrin International
For further information on Fifth Disease click here
Website Design by Net Affinity
93 The Rise, Mount Merrion, Co. Dublin, Ireland.
Tel: +353 1 283 1166 | Fax: +353 1 283 1232 | Email: info@biotrin.ie
For technical support please email customercare@biotrin.ie